These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21281682)

  • 21. Seronegative autoimmune hepatitis presenting after diagnosis of coeliac disease: a case report.
    Quail MA; Russell RK; Bellamy C; Mieli-Vergani G; Gillett PM
    Eur J Gastroenterol Hepatol; 2009 May; 21(5):576-9. PubMed ID: 19318969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of immunomodulary agents is difficult in treating autoimmune hepatitis patients.
    Gordon FD; Simpson M
    J Clin Gastroenterol; 2004 Oct; 38(9):729-30. PubMed ID: 15365394
    [No Abstract]   [Full Text] [Related]  

  • 23. Reply to: Comments on "An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis".
    Snijders RJALM; Stoelinga AEC; van Hoek B; Drenth JPH
    J Hepatol; 2024 Jul; 81(1):e43-e44. PubMed ID: 38554845
    [No Abstract]   [Full Text] [Related]  

  • 24. Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy.
    Inductivo-Yu I; Adams A; Gish RG; Wakil A; Bzowej NH; Frederick RT; Bonacini M
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):799-802. PubMed ID: 17509945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy.
    Sharzehi K; Huang MA; Schreibman IR; Brown KA
    Can J Gastroenterol; 2010 Oct; 24(10):588-92. PubMed ID: 21037986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis.
    Hlivko JT; Shiffman ML; Stravitz RT; Luketic VA; Sanyal AJ; Fuchs M; Sterling RK
    Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1036-40. PubMed ID: 18586559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up.
    Aw MM; Dhawan A; Samyn M; Bargiota A; Mieli-Vergani G
    J Hepatol; 2009 Jul; 51(1):156-60. PubMed ID: 19446911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients.
    Zachou K; Gatselis N; Papadamou G; Rigopoulou EI; Dalekos GN
    J Hepatol; 2011 Sep; 55(3):636-646. PubMed ID: 21238519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis.
    Efe C; Taii HA; Ytting H; Aehling N; Bhanji RA; Hagström H; Purnak T; Muratori L; Werner M; Muratori P; Klintman D; Schiano TD; Montano-Loza AJ; Berg T; Larsen FS; Alkhouri N; Ozaslan E; Heneghan MA; Yoshida EM; Wahlin S
    Dig Dis Sci; 2018 May; 63(5):1348-1354. PubMed ID: 29569003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolving new therapies of autoimmune hepatitis.
    Vierling JM; Flores PA
    Clin Liver Dis; 2002 Aug; 6(3):825-50, ix. PubMed ID: 12362583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of severe refractory lupus hepatitis with mycophenolate mofetil.
    Tagawa Y; Saito T; Takada K; Kawahata K; Kohsaka H
    Lupus; 2016 Apr; 25(5):543-6. PubMed ID: 26762472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mycophenolate mofetil: an alternative treatment for refractory autoimmune hemolytic anemia in children].
    Navarro Mingorance A; Jimenez García I; Galera Miñarro AM; Fuster Soler JL
    An Pediatr (Barc); 2012 Jul; 77(1):64-5. PubMed ID: 22483537
    [No Abstract]   [Full Text] [Related]  

  • 33. [Auto-immune hepatitis: therapeutic management].
    Pariente A
    Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B13-9. PubMed ID: 12843932
    [No Abstract]   [Full Text] [Related]  

  • 34. Mycophenolate mofetil prevents development of urinary protein in autoimmune nephritis.
    Takeda S; Takahashi M; Kusano E; Kobayashi E
    Kidney Int; 2003 Jul; 64(1):365-6; author reply 366. PubMed ID: 12787433
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatitis C and mycophenolate mofetil--a clarification.
    Fasola CG; Klintmalm GB
    Liver Transpl; 2002 Apr; 8(4):411-2; author reply 412-3. PubMed ID: 11965590
    [No Abstract]   [Full Text] [Related]  

  • 36. [Mycophenolate mofetil, a possible new immunosuppresant].
    Weberová J; Voboril R; Semecký V
    Ceska Slov Farm; 2002 Sep; 51(5):220-5. PubMed ID: 12407919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treating chronic severe hepatitis B patients with mycophenolate mofetil].
    Yang YF; Tan DM; Xie YT; Lu MH; Liu ZB; Sha XP; Liu GZ; Wang L
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):392-3. PubMed ID: 15918985
    [No Abstract]   [Full Text] [Related]  

  • 38. Mycophenolate mofetil: new applications for this immunosuppressant.
    Moder KG
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):15-19; quiz 20, 78. PubMed ID: 12546332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycophenolate mofetil monotherapy for pemphigus vulgaris.
    Bredlich RO; Grundmann-Kollmann M; Behrens S; Kerscher M; Peter RU
    Br J Dermatol; 1999 Nov; 141(5):934. PubMed ID: 10583186
    [No Abstract]   [Full Text] [Related]  

  • 40. Induction of remission in a child with autoimmune enteropathy using mycophenolate mofetil.
    Quirós-Tejeira RE; Ament ME; Vargas JH
    J Pediatr Gastroenterol Nutr; 2003 Apr; 36(4):482-5. PubMed ID: 12658040
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.